Xencor Inc. diskutieren
Xencor Inc.
WKN: A1W96L / Symbol: XNCR / Name: Xencor / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
16,80 €
-1,18 %
Xencor (NASDAQ:XNCR) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor (XNCR) had its price target raised by Barclays PLC from $26.00 to $27.00. They now have an "overweight" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor (XNCR) had its price target lowered by Truist Financial Corporation from $29.00 to $27.00. They now have a "buy" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor (XNCR) had its "outperform" rating reaffirmed by Wedbush. They now have a $26.00 price target on the stock.
Ratings data for XNCR provided by MarketBeat
Xencor (XNCR) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Ratings data for XNCR provided by MarketBeat
Xencor (XNCR) had its price target raised by Wedbush from $26.00 to $30.00. They now have an "outperform" rating on the stock.
Ratings data for XNCR provided by MarketBeat
Neueste Beiträge
TD_Cowen in Cogent Communications Hldg. Inc. diskutieren